123 related articles for article (PubMed ID: 30779874)
1. Efficient Intracellular Delivery of CRISPR-Cas Ribonucleoproteins through Receptor Mediated Endocytosis.
Rouet R; Christ D
ACS Chem Biol; 2019 Mar; 14(3):554-561. PubMed ID: 30779874
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
3. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
Campbell LA; Richie CT; Maggirwar NS; Harvey BK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein.
Qiao J; Sun W; Lin S; Jin R; Ma L; Liu Y
Chem Commun (Camb); 2019 Apr; 55(32):4707-4710. PubMed ID: 30942216
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated delivery of CRISPR-Cas9 ribonucleoproteins in human cells.
Ubiparipovic S; Christ D; Rouet R
Protein Eng Des Sel; 2022 Feb; 35():. PubMed ID: 36336952
[TBL] [Abstract][Full Text] [Related]
6. One-in-one individual package and delivery of CRISPR/Cas9 ribonucleoprotein using apoferritin.
Pan X; Pei X; Huang H; Su N; Wu Z; Wu Z; Qi X
J Control Release; 2021 Sep; 337():686-697. PubMed ID: 34389365
[TBL] [Abstract][Full Text] [Related]
7. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
8. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
[TBL] [Abstract][Full Text] [Related]
9. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
Bykonya AG; Lavrov AV; Smirnikhina SA
Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
[TBL] [Abstract][Full Text] [Related]
10. The Implications of CRISPR-Cas9 Genome Editing for IR.
Perkons NR; Sheth R; Ackerman D; Chen J; Saleh K; Hunt SJ; Nadolski GJ; Shi J; Gade TP
J Vasc Interv Radiol; 2018 Sep; 29(9):1264-1267.e1. PubMed ID: 30146193
[No Abstract] [Full Text] [Related]
11. Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.
Foss DV; Muldoon JJ; Nguyen DN; Carr D; Sahu SU; Hunsinger JM; Wyman SK; Krishnappa N; Mendonsa R; Schanzer EV; Shy BR; Vykunta VS; Allain V; Li Z; Marson A; Eyquem J; Wilson RC
Nat Biomed Eng; 2023 May; 7(5):647-660. PubMed ID: 37147433
[TBL] [Abstract][Full Text] [Related]
12. Knocking out consumer concerns and regulator's rules: efficient use of CRISPR/Cas ribonucleoprotein complexes for genome editing in cereals.
Wolter F; Puchta H
Genome Biol; 2017 Feb; 18(1):43. PubMed ID: 28245842
[TBL] [Abstract][Full Text] [Related]
13. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
14. Diversity and evolution of class 2 CRISPR-Cas systems.
Shmakov S; Smargon A; Scott D; Cox D; Pyzocha N; Yan W; Abudayyeh OO; Gootenberg JS; Makarova KS; Wolf YI; Severinov K; Zhang F; Koonin EV
Nat Rev Microbiol; 2017 Mar; 15(3):169-182. PubMed ID: 28111461
[TBL] [Abstract][Full Text] [Related]
15. Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds.
Teng F; Li J; Cui T; Xu K; Guo L; Gao Q; Feng G; Chen C; Han D; Zhou Q; Li W
Genome Biol; 2019 Feb; 20(1):15. PubMed ID: 30717767
[TBL] [Abstract][Full Text] [Related]
16. Genome editing: The domestication of Cas9.
Urnov F
Nature; 2016 Jan; 529(7587):468-9. PubMed ID: 26819037
[No Abstract] [Full Text] [Related]
17. Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.
Liang Z; Chen K; Li T; Zhang Y; Wang Y; Zhao Q; Liu J; Zhang H; Liu C; Ran Y; Gao C
Nat Commun; 2017 Jan; 8():14261. PubMed ID: 28098143
[TBL] [Abstract][Full Text] [Related]
18. Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing.
Rouet R; Thuma BA; Roy MD; Lintner NG; Rubitski DM; Finley JE; Wisniewska HM; Mendonsa R; Hirsh A; de Oñate L; Compte Barrón J; McLellan TJ; Bellenger J; Feng X; Varghese A; Chrunyk BA; Borzilleri K; Hesp KD; Zhou K; Ma N; Tu M; Dullea R; McClure KF; Wilson RC; Liras S; Mascitti V; Doudna JA
J Am Chem Soc; 2018 May; 140(21):6596-6603. PubMed ID: 29668265
[TBL] [Abstract][Full Text] [Related]
19. Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice.
Li L; Song L; Liu X; Yang X; Li X; He T; Wang N; Yang S; Yu C; Yin T; Wen Y; He Z; Wei X; Su W; Wu Q; Yao S; Gong C; Wei Y
ACS Nano; 2017 Jan; 11(1):95-111. PubMed ID: 28114767
[TBL] [Abstract][Full Text] [Related]
20. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
